P2-12-28: Studies of a Malignancy-Associated Protein, Osteopontin, in NCIC CTG MA.14, a Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR in Adjuvant Treatment of Women with Early Breast Cancer. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Bramwell, VH
  • Tuck, AB
  • Chapman, J-A
  • Anborgh, PH
  • Postenka, CO
  • Shepherd, L
  • Pritchard, Kathleen
  • Han, L
  • Wilson, C
  • Pollak, M
  • Chambers, AF

publication date

  • December 15, 2011